"An investment in knowledge pays the best interest."



WeedMD Inc. (WMD.V) has received an amendment to its licence from Health Canada to include the sale of dried cannabis products from its facility in Aylmer, Ont. In addition, the company was licensed to sell starting materials to patients wishing to grow their own medicine under ACMPR (access to cannabis for medical purposes regulations), a practice WeedMD strongly supports. Full product offerings will appear on the WeedMD website when available.

"Obtaining our licence to sell dried cannabis products is another major milestone for WeedMD. The expedited nature of the sales amendment came ahead of schedule and accelerates our timeline to revenue generation, and is a direct result of the dedication and quality efforts of our entire team," said Bruce Dawson-Scully, chief executive officer of WeedMD. "We look forward to opening our doors to patients and are excited to serve both patients in the long-term care and senior market, as well the broader medical patient community."

The licence capacity has been amended, and the fully retrofitted 26,000-square-foot indoor facility is now licensed to produce and sell 1,200 kilograms of dried medical cannabis. In anticipation of the approval to sell, the company has produced an inventory of approximately 300 kilograms of dried cannabis product. The facility is currently capable of producing up to 1,300 kilograms of dried cannabis per annum, with intentions to build out an oil extract lab as well further mothering and nursery rooms that could augment current production by up to 40 per cent.